Skip to main content

Table 1 Patients characteristics (N = 253)

From: Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study

Characteristics

 

N (%)

Age (years)

≤65

125 (49.4%)

Sex

Male

161 (63.6%)

Smoking status

Yes

96 (86.5%)

ECOG PSa

0

75 (52.9%)

1

31 (21.8%)

2

17 (12%)

3

8 (5.6%)

4

11 (7.7%)

TNM stage

I

9 (3.8%)

II

28 (12%)

III

34 (14.6%)

IV

163 (69.6%)

Tumor size

T 1

22 (9.2%)

T 2

71 (29.7%)

T 3

69 (28.9%)

T 4

77 (32.2%)

Lymph node

Positive

177 (75%)

Metastasis

Yes

163 (69.4%)

ERCC1

≤0.1

68 (52.7%)

>  0.1

61 (47.3%)

Therapyb

C

142 (77.2%)

C + S

26 (14.1%)

C + R

16 (8.7%)

  1. aECOG PS Eastern Cooperative Oncology Group Performance Status
  2. bC chemotherapy, S surgical resection, R radiotherapy